Study on the Clinical Safe and Effective Methods of Arsenic-Containing Compound-Qinghuang Powder in the Treatment of Myelodysplastic Syndrome
Objective. To establish the clinical safe and effective methods of arsenic-containing compound-Qinghuang Powder (compound-QHP) in the treatment of myelodysplastic syndrome (MDS). Methods. 200 patients with MDS were treated with compound-QHP (daily dose of 0.1 g realgar). The blood arsenic concentrat...
Main Authors: | Qianzhe Zhu, Zhongyang Deng, Shirong Zhu, Pan Zhao, Mingjing Wang, Xiaomei Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/2095682 |
Similar Items
-
Deciphering the Key Pharmacological Pathways and Targets of Yisui Qinghuang Powder That Acts on Myelodysplastic Syndromes Using a Network Pharmacology-Based Strategy
by: Zijian Han, et al.
Published: (2020-01-01) -
Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic
by: Sun Shuzhen, et al.
Published: (2012-01-01) -
Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome
by: Zhou QB, et al.
Published: (2020-04-01) -
SET Domain Containing 2 Deficiency in Myelodysplastic Syndrome
by: Jiaming Li, et al.
Published: (2020-08-01) -
Myelodysplastic Syndromes
Published: (2016)